## Abstract Treatment with antiβCD3 mAb modulates immune responses that cause type 1 diabetes and other diseases. CD8^+^ Tregs can be induced in vitro and in vivo by mAb. However, 1/3 of patients do not respond to drug therapy and in an equal proportion, antiβCD3 mAb does not induce Tregs in vitro.
β¦ LIBER β¦
A clonal model for human CD8+ regulatory T cells: Unrestricted contact-dependent killing of activated CD4+ T cells
β Scribed by Dan Hu; Xia Liu; Wanyong Zeng; Howard L. Weiner; Jerome Ritz
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 378 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
NKG2A is a marker for acquisition of reg
β
Vitaly Ablamunits; Octavian Henegariu; Paula Preston-Hurlburt; Kevan C. Herold
π
Article
π
2011
π
John Wiley and Sons
π
English
β 435 KB
π 1 views
CD8Ξ± is an activation marker for a subse
β
Emma Kenny; Don Mason; Abdelhadi Saoudi; Ana Pombo; Francisco RamΓrez
π
Article
π
2004
π
John Wiley and Sons
π
English
β 296 KB
Clonal analysis of CD4 CD8- human thymoc
β
Maria Cristina Mingari; Paola Varese; Cristina Bottino; Giovanni Melioli; Alessa
π
Article
π
1988
π
John Wiley and Sons
π
English
β 415 KB
π 1 views
Control of type 1 diabetes by CD4+Foxp3+
β
Evridiki Sgouroudis; Ciriaco A. Piccirillo
π
Article
π
2009
π
John Wiley and Sons
π
English
β 357 KB
Cytotoxic CD4+ and CD8+ T lymphocytes, g
β
Marianne K. Gjertsen; Jens BjΓΈrheim; Ingvil Saeterdal; June Myklebust; Gustav Ga
π
Article
π
1997
π
John Wiley and Sons
π
French
β 119 KB
π 1 views
Mutant p21-ras proteins contain sequences that distinguish them from normal ras, and represent unique epitopes for T-cell recognition of antigen-bearing tumour cells. Here, we examined the capacity of CD4 Ψ and CD8 Ψ T cells, generated simultaneously by mutant-ras-peptide vaccination of a pancreatic